A morbidity study of former pentachlorophenol-production workers

Environmental Health Perspectives

Volumn 106, Issue 7, 1998, Pages 401-408

  Hryhorczuk, Daniel O ^a,b   Wallace, Warren H ^a   Persky, Victoria ^a,b   Furner, Sylvia ^b   Webster Jr , James R ^a   Oleske, Denise ^c   Haselhorst, Barbara ^e   Ellefson, Ralph ^d   Zugerman, Charles ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c RUSH UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e NONE

Author keywords

Chloracne; Chlorinated dibenzo p dioxins; Dibenzofurans; Occupational exposures; Pentachlorophenol; Porphyrins

Indexed keywords

COPROPORPHYRIN; PENTACHLOROPHENOL; PESTICIDE; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; PORPHYRIN;

ARTICLE; CENTRAL NERVOUS SYSTEM; CHLORACNE; CONTAMINATION; CONTROLLED STUDY; HEALTH STATUS; HUMAN; LIVER; MEDICAL RECORD; MORBIDITY; OCCUPATIONAL EXPOSURE; PERIPHERAL NERVOUS SYSTEM; PHYSICAL EXAMINATION; PORPHYRIN METABOLISM; PRESERVATION; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN; URINALYSIS; WOOD;

EID: 0031726664     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106401     Document Type: Article

References (63)

1. U.S. EPA. Final determination and intent to cancel and deny applications for registrations of pesticide products containing pentachlorophenol (including but not limited to its salts and esters) for non-wood uses. Fed Reg 52:2282-2293 (1987).
2. NTP. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures (CAS No 87-86-5) in B6C3F1 Mice (Feed Studies).TR 349. Research Triangle Park, NC:National Toxicology Program, 1989.
3. Wood S, Rom WN, White GL, Logan DC. Pentachlorophenol poisoning. J Occup Med 25:527-530 (1983).
4. Baader EW, Bauer HG. Industrial intoxication due to pentachlorophenol. Ind Med Surg 20:286-290 (1951).
5. Triebig G, Krekeler H, Gossler K, Valentin H. Untersuchungen zur Neurotoxizitat von Arbeitsstoffen. Int Arch Occup Environ Health 48:357-367 (1981).
6. Zober A, Schaller KH, Gobler K, Krekeler HJ. Pentachlorophenol und Leberfunktion. Int Arch Occup Environ Health 48:347-356 (1981).
7. Bauchinger M, Dresp J, Schmid E, Hauf R. Chromosome changes in lymphocytes after occupational exposure to pentachlorophenol, Mutat Res 102:83-88 (1982).
8. Baxter RA. Biochemical study of pentachlorophenol workers. Ann Occup Hyg 4:429-438 (1984).
9. O'Malley MA, Carpenter AV, Sweeney MH, Fingerhut MA, Marlow DA, Halperin WE, Mathias CG. Chloracne associated with employment in the production of pentachlorophenol, Am J Ind Med 17:411-421 (1990).
10. Cheng WN, Coenraads PJ, Hao ZH, Liu GF. A health survey of workers in the pentachlorphenol section of a chemical manufacturing plant. Am J Ind Med 24:81-92 (1993).
11. Jones RD, Winter DP, Cooper AJ. Absorption study of pentachlorophenol in persons working with wood preservatives. Hum Toxicol 5:189-194 (1986).
12. Begley J, Reichert EL, Rashad MN, Klemmer HW, Association between renal function tests and pentachlorophenol exposure, Clin Toxicol 11:97-106 (1977).
13. Klemmer HW, Wong L, Sato MM, Reichart EL, Korsak RJ, Rashad MN. Clinical findings in workers exposed to pentachlorophenol. Arch Environ Contam Toxicol 9:715-725 (1980).
14. Embree B, Enarson DA, Chan-Yeung M, DyBuncio A, Dennis R, Leach J. Occupational exposure to chlorophenates:toxicology and respiratory effects. Clin Toxicol 22:317-329 (1984).
15. Enarson DA, Chan-Yeung M, Embree V, Wang R, Schulzer M. Occupational exposure to chlorophenates, Scand J Work Environ Health 12:144-148 (1986).
16. Kleinman GO, Horstman SW, Kalman DA, McKenzie J, Stansel D. Industrial hygiene, chemical and biological assessments of exposures to a chlorinated phenolic sapstain control agent. Am Ind Hyg Assoc J 47:731-741 (1986).
17. Sehgal VN, Ghorpade A. Fume inhalation chloracne. Dermatologica 167:33-36 (1983).
18. Cole GW, Stone O, Gates D, Culver D. Chloracne from pentachlorophenol-preserved wood. Contact Dermatitis 15:164-168 (1986).
19. NCHS. Current estimates from the National Health Interview Survey, United States, 1986. Data from the National Health Survey. Vital and Health Statistics, Series 10, No 164. PHS Publication No 87-1592. Hyattsville, MD:National Center for Health Statistics, 1987.
20. Calvert GM, Hornung RW, Haring Sweeney M, Fingerhut MA, Halperin WE. Hepatic and gastrointestinal effects in an occupational cohort exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA 267:2209-2214 (1992).
21. MRC Committee on the Aetiology of Chronic Bronchitis. Standardised questionnaires on respiratory symptoms. Br Med J 2:1665 (1960).
22. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial-risk factor changes and mortality results, JAMA 248:1465-1477 (1982).
23. Hogstedt C, Andersson K, Hane M. A questionnaire approach to the monitoring of early disturbances in central nervous functions, In:The Biological Monitoring and Surveillance of Workers Exposed to Chemicals (Aitio A, Riihimaki V, Vainio H, eds). Washington, DC:Hemisphere Publishing Corporation, 1984.
24. Schwartz S, Berg MH, Bossenmaier I. Methods of Biochemical Analysis, Vol 8 (Glick D, ed). New York:Interscience Publishers, 1960;249.
25. Ford RE, Ou C-N, Ellefson RD. Liquid Chromatographic analysis for urinary porphyrins, Clin Chem 27:397-401 (1981).
26. SAS Institute. SAS Users Guide, Version 5. Cary, NC:SAS Institute, Inc., 1985.
27. Braun WH, Blau GE, Chenoweth MB. The Metabolism/Pharmacokinetics of Pentachlorophenol in Man, and a Comparison with the Rat and Monkey. Midland, MI:Toxicology Research Laboratory, Dow Chemical, 1978.
28. Flesch-Janys D, Becher H, Gurn P, Jung D, Konietzko J, Manz A, Papke O, Elimination of polychlorinated dibenzo-p-dioxins and dibenzofurans in occupationally exposed persons. J Toxicol Environ Health 47:363-378 (1996).
29. Butler MG. Acneiform dermatosis produced by ortho (2 chlorophenyl) phenol sodium and tetrachlorophenol sodium. Arch Dermatol Syphilol 35:252-254 (1937).
30. Stingily KO. A new industrial chemical dermatitis. S Med J 33:1268-1272 (1940).
31. Moses M, Lilis R, Thornton J, Fischbein A, Crow KD, Anderson HA, Selikoff IJ. Health status of workers with past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the manufacture of 2,4,5-trichlorophenoxyacetic acid:comparison of findings with and without chloracne. Am J Ind Med 5:161-182 (1984).
32. Suskind RR, Hertzberg VS. Human health effects of 2,4,5-T and its toxic contaminants, JAMA 252:2372-2380 (1984).
33. May G, Tetrachlorodibenzodioxin:a survey of subjects ten years after exposure. Br J Ind Med 39:128-135 (1982).
34. Goldman PJ. Schwerste akute chloracne, eine massenintoxikation durch 2,3,6,7-tetrachlordibenzodioxin. Hautarzt 24:149-152 (1973).
35. Pazderova-Veljlupkova J, Nemcova M, Pickova J, Jirasek L, Lukas E. The development and prognosis of chronic intoxication by tetrachlorodibenzo-p-dioxin in men. Arch Environ Health 36:5-11 (1981).
36. Poland AP, Smith D, Matter G, Possick P. A health survey of workers in a 2,4-D and 2,4,5-T plant with special attention to chloracne, porphyria cutanea tarda, and psychologic parameters, Arch Environ Health 22:316-327 (1971).
37. Bleiberg J, Wallen M, Brodkin R, Applebaum IL. Industrially acquired porphyria. Arch Dermatol 89:793-797 (1964).
38. Dugois P, Amblard P, Almard M, Deshors G. Acne chlorique collective et accidentell d'un type nouveau. Bull Soc Fr Dermatol Syphiligr 75:260-261 (1968).
39. Mocarelli P, Marocchi A, Brambilla P, Gerthoux PM, Young DS, Mantel N. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 256:2687-2695 (1986).
40. Doss M, Sauer H, von Tipermann R, Colombi AM. Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin. Int J Biochem 16:369-373 (1984).
41. Centen AHJ, Strik JJ, Colombi A. Coproporphyrinuria and chronic hepatic porphyria type A found in people from Seveso (Italy) exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In:Chemical Porphyria in Man (Strik JJ, Koeman JH, eds). Amsterdam:Elsevier/North-Holland Biomedical Press, 1979;75-81.
42. Bauer H, Schulz H, Spielberg V. Occupational intoxication during the production of chlorphenol compounds. Arch Gewerbe path Gewerbehyg 18:538-555 (1961).
43. Oliver RM. Toxic effects of 2,3,7,8 tetrachlordibanzo 1,4 dioxin in laboratory workers. Br J Ind Med 32:49-53 (1975).
44. Lathrop GD, Wolfe W, Machado SG, Karrison TG, Grubbs WD, Thomas WF, Michalek JE, Minor JC, Peterson MR, Ogerschok RW, An Epidemiologic Investigation of Health Effects in Air Force Personnel Following Exposure to Herbicides:Baseline Morbidity Results, NTIS No. AD A 128 340. Springfield, VA:National Technical Information Service, 1984.
45. Hoffman RE, Stehr-Green PA, Webb KB, Evans RG, Knutsen AP, Schramm WF, Staake JL, Gibson BB, Steinberg KK. Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA 255:2031-2038 (1986).
46. Walker AE, Martin JV. Lipid profiles in dioxin-exposed workers, Lancet 1:446-447 (1979).
47. Martin JV. Lipid abnormalities in workers exposed to dioxin. Br J Ind Med 41:254-256 (1984).
48. Pocchiari F, Silano V, Zampieri A. Human health effects from accidental release of tetrachlorodibenzo-p-dioxin in Seveso, Italy. Ann NY Acad Sci 320:311-320 (1979).
49. Filippini G, Bordo B, Crenna P, Masseto N, Musicco M, Boeri R. Relationship between clinical and electrophysiological findings and indicators of heavy exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Scand J Work Environ Health 7:257-262 (1981).
50. Barbieri S, Pirovan C, Scarlato G, Tarchinini P, Zappa A, Maranzana M. Long-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the peripheral nervous system-clinical and neurophysiological controlled study on subjects with chloracne from the Seveso area. Neuroepidemiology 7:29-37 (1988).
51. Singer R, Moses M, Valciukas J, Lilis R, Selikoff IJ. Nerve conduction velocity studies of workers employed in the manufacture of phenoxy herbicides. Environ Res 29:297-311 (1982).
52. Johnson RL, Gehring PJ, Kociba RJ, Schwertz BA. Chlorinated dibenzodioxins and pentachlorophenol. Environ Health Perspect 5:171-175 (1973).
53. Jones RE, Chelsky M, Further discussion concerning porphyria cutanea tarda and TCDD exposure. Arch Environ Health 41:100-103 (1986).
54. Calvert GM, Sweeney MH, Fingerhut MA, Hornung RW, Halperin WE. Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Ind Med 25:559-571 (1994).
55. Pines A, Cucos S, Grafstein O, Guttman-Bass N, Lemesh C, Rav-Acha C, Urine porphyrin metabolites in wood workers:a pilot study. Med Lav 79:386-389 (1988).
56. Maroni M, Emmet EA, Fait A. Porphyrinogenesis study in workers exposed to polychlorinated biphenyls. In:Occupational and Environmental Chemical Hazards (Fao V, Emmatt EA, Maroni M, Colombi AM, eds). Chichester, UK:Ellis Horwood, 1987;264-271.
57. Goldstein JA, Friesen M, Linder RE, Hickman P, Hass JR, Bergman L, Effects of pentachlorphenol on hepatic drug-metabolizing enzymes and porphyria related to contamination with chlorinated dibenzo-p-dioxins and dibenzofurans. Biochem Pharm 26:1549-1557 (1977).
58. Doss MO, Colombi AM. Chronic hepatic porphyria Induced by chemicals:the example of dioxin. In:Occupational and Environmental Chemical Hazards (Fao V, Emmett EA, Maroni M, Colombi AM, eds). Chicester, UK:Ellis Horwood, 1987;231-240.
59. Van Birgelen APJM, Fase KM, Van der Kolk J, Poiger H, Brouwer A, Seinen W, Van den Berg M. Synergistic effect of 2,2′,4,4′,5,5′-hexachlorobiphenyl and 2,3,7,8-tetrachlorobibenzo-p-dioxin on hepatic prophyrin levels in the rat. Environ Health Perspect 104:550-557 (1996).
60. Noweir MH, Pfitzer EA. Evaluation of coproporphyrin in urine from workers exposed to lead. Am Ind Hyg Assoc J 31:492-500 (1970).
61. Fingerhut MA, Haring-Sweeney M, Patterson DG, Piacitelli LA, Morris JA, Marolow DA, Hornung RW, Cameron LW, Connally LB, Needam LL, Halperin WE. Levels of 2,3,7,8-TCDD in the serum of U.S. chemical workers exposed to dioxin contaminated products:interim results. Chemosphere 19:835-840 (1989).
62. Neuberger M, Landvoigt W, Derntl F. Blood levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in chemical workers after chloracne and in comparison groups. Int Arch Occup Environ Health 63:325-327 (1991).
63. Beck H, Eckart K, Mathar W, Wittkowski R. Levels of PCDDs and PCDFs in adipose tissue of occupationally exposed workers. Chemosphere 18:507-516 (1989).